- Kidney, Liver Transplant Study for People With HIV
A study of liver and kidney transplants for persons with HIV, at 19 U.S. transplant centers, is open to new patients. Those who may need a transplant later might benefit by getting into the system in advance to avoid delays.
- HIV "New Strain" Story: For More Information
AIDS community groups have brought together background documents, explanatory writeups, and other information about the media stories that resulted from what is still a single, ambiguous case.
- HIV: More Voluntary Testing Recommended
Two research articles and an editorial in the New England Journal of Medicine recommend routine HIV testing for most of the U.S. population. The goal is to start treatment early when it can be more effective -- and also to reduce transmission from the hundreds of thousands of Americans who do not know they have HIV
- Early Medicaid Treatment: Bipartisan Bill in Senate With 32 Cosponsors, Could Cut HIV Deaths on Medicaid in Half
A bill to allow states to treat HIV early under Medicaid, instead of waiting for disabling illness, could prevent half of the HIV deaths in that program.
- Tat Inhibitors, A New Approach: Interview With Olaf Kutsch, Ph.D.
An important potential target for antiretrovirals is the HIV protein Tat (produced by the virus and essential for infection, but is not used by the human body). Years ago, a Tat inhibitor worked well in the laboratory but failed in patients. Modern biotechnology may have shown why -- and how to screen for drugs more likely to work.
- If the Condom Breaks: New U.S. Guidelines for Non-Occupational Exposure to HIV
Finally there are U.S.-government guidelines for prevention of non-occupational HIV exposure, for example after rape or accident.
- Global Good News: Many More Treated
A combination of financing from rich countries, determination and effort by local governments, effective teamwork, and successful scale-up of treatment access despite obstacles, has doubled the number of people receiving treatment in sub-Saharan Africa (and also in East, South, and Southeast Asia) in six months.
- FDA Advisory on Nevirapine
The FDA summarized existing warnings against ongoing nevirapine treatment in women with a CD4 count over 250, due to a greatly increased risk of serious liver toxicity. (The warnings do not apply to single-dose nevirapine, which does not cause this problem.)
- Conferences and Meetings Calendar, 2005
Here are some important AIDS treatment-related conferences for March through December 2005.
ISSN # 1052-4207
Copyright 2005 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.